Biotech entity
pharma is the sole category represented across all 1 tracked stories. CBER is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 6 original sources each. Vaccine Chief appears in 1 tracked Biotech story from March 7, 2026.
Last mentioned: Mar 7, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. CBER is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 6 original sources each. Vaccine Chief appears in 1 tracked Biotech story from March 7, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Vaccine Chief. Shared-story counts are live from our verified record — not editorial picks.
The head of the FDA’s vaccine division is stepping down for the second time, marking a significant leadership vacuum at a critical juncture for the agency. This departure follows a period of intense scrutiny and reported friction between the regulatory body and the Trump administration over vaccine authorization protocols.
Vaccine Chief is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
